<?xml version="1.0" encoding="UTF-8"?>
<!--
  EXECUTION PLAN 03: LaTeX Manuscript Updates
  Priority: P2-MEDIUM
  Purpose: Sync figure report findings with manuscript .tex files

  Cold-Start Context:
  - Manuscript is in: /home/petteri/Dropbox/github-personal/sci-llm-writer/manuscripts/foundationPLR/
  - Main tracking file: manuscript-comments.xml (41 comments, 10 themes)
  - CLAUDE.md defines scope: TSFM preprocessing is CORE, classification is proxy
  - EPV should be 7.0 (8 features from featuresSimple.yaml)

  Self-Contained: This plan has ALL context needed for execution from cold start.
-->
<execution-plan id="03-latex-updates" version="1.0">
  <metadata>
    <created>2026-01-29</created>
    <priority>P2-MEDIUM</priority>
    <estimated-effort>3-4 hours</estimated-effort>
    <manuscript-path>/home/petteri/Dropbox/github-personal/sci-llm-writer/manuscripts/foundationPLR/</manuscript-path>
    <comments-tracker>iterated-llm-council/04-improvements-from-comments/manuscript-comments.xml</comments-tracker>
  </metadata>

  <context>
    <manuscript-scope>
      This paper evaluates TSFM preprocessing utility, NOT classifier development.
      Classification (N=208, 56 events) is a downstream proxy for preprocessing quality (N=507).
    </manuscript-scope>
    <key-values>
      <value name="GT_AUROC">0.9110</value>
      <value name="BEST_AUROC">0.9130</value>
      <value name="EPV">7.0</value>
      <value name="N_PREPROCESSING">507</value>
      <value name="N_CLASSIFICATION">208</value>
    </key-values>
    <related-plans>
      - manuscript-comments.xml: 41 author comments tracking
      - CLAUDE.md: Manuscript scope and guardrails
    </related-plans>
  </context>

  <!-- PHASE 1: METHODS.TEX UPDATES -->
  <phase id="1-methods" name="Methods Section Updates">
    <file>methods.tex</file>

    <step id="1.1">
      <task>Add EPV calculation</task>
      <location>After feature extraction description</location>
      <text><![CDATA[
With 56 glaucoma events and 8 handcrafted features (4 amplitude bins per color
from \texttt{featuresSimple.yaml}), our events-per-variable ratio is $\text{EPV} = 7.0$,
meeting minimum guidelines for prediction model development~\citep{riley_calculating_2020}.
For MOMENT embeddings (96 dimensions), $\text{EPV} = 0.58$ precludes reliable inference;
embedding-based results should be interpreted as exploratory.
      ]]></text>
      <related-comment>METH-01 (verify dimensionality)</related-comment>
    </step>

    <step id="1.2">
      <task>Clarify preprocessing vs featurization scope</task>
      <location>Methods opening</location>
      <text><![CDATA[
We define \emph{preprocessing} as signal cleaning operations (outlier detection,
imputation, baseline correction) and \emph{featurization} as discriminative
feature extraction from the cleaned signal. This distinction is important:
TSFMs may excel at preprocessing (generic temporal patterns suffice) while
underperforming for featurization (domain knowledge essential).
      ]]></text>
      <related-comment>DISC-02 (scope definitions)</related-comment>
    </step>

    <step id="1.3">
      <task>Add sample size clarification</task>
      <text><![CDATA[
Preprocessing quality was evaluated on $N=507$ subjects (approximately 1 million
timepoints). Classification performance was assessed on the $N=208$ labeled subset
(152 control, 56 glaucoma), with classification serving as a downstream proxy
for preprocessing impact rather than a primary clinical validation endpoint.
      ]]></text>
    </step>
  </phase>

  <!-- PHASE 2: DISCUSSION.TEX UPDATES -->
  <phase id="2-discussion" name="Discussion Section Updates">
    <file>discussion.tex</file>

    <step id="2.1">
      <task>Replace placeholder numbers (-?-, 0.???)</task>
      <location>Multiple locations per DISC-03, DISC-04, DISC-05</location>
      <values>
        <replace from="-?-" to="specific numbers from DuckDB"></replace>
        <replace from="0.???" to="verified AUROC values"></replace>
      </values>
      <related-comments>DISC-03, DISC-04, DISC-05 (placeholder numbers)</related-comments>
    </step>

    <step id="2.2">
      <task>Add pilot study framing paragraph</task>
      <location>Limitations section</location>
      <text><![CDATA[
Several limitations warrant consideration. First, this is a proof-of-concept
pilot study demonstrating TSFM preprocessing feasibility, not a clinical
validation study. With $N=208$ labeled subjects (56 glaucoma events) and
$\text{EPV} = 7.0$ for handcrafted features, calibration instability is
statistically expected~\citep{riley_clinical_2023} and does not diminish the
preprocessing findings, which represent the study's core contribution.
The calibration slope of 0.52 indicates model overconfidence typical of
small-sample development; we explicitly chose not to apply post-hoc
recalibration to avoid masking this fundamental limitation.
      ]]></text>
    </step>

    <step id="2.3">
      <task>Add dimensionality reduction caveat</task>
      <location>Embedding discussion</location>
      <text><![CDATA[
The observed performance gap between MOMENT embeddings ($\text{AUROC} = 0.704$)
and handcrafted features ($\text{AUROC} = 0.830$) cannot be definitively attributed
to representation quality without controlling for dimensionality. Future research
should systematically compare embeddings at matched feature lengths (8, 16, 32, 64, 96)
using dimensionality reduction techniques (PCA, UMAP, NMF) or learned adapters.
      ]]></text>
      <related-comment>Author caveat on dimensionality</related-comment>
    </step>

    <step id="2.4">
      <task>Add uncertainty propagation discussion</task>
      <location>Future directions</location>
      <text><![CDATA[
A critical limitation of current PLR analysis is the treatment of preprocessing
uncertainty. Studies typically report downstream classification metrics without
propagating input uncertainty through the pipeline~\citep{mure_melanopsin_2009}.
Future end-to-end systems should incorporate uncertainty quantification at each
stage: SAMv3 pupil segmentation (with pixel-level confidence), TSFM reconstruction
(with per-timepoint uncertainty), and calibrated classification (with selective
abstention for uncertain predictions).
      ]]></text>
      <related-comment>DISC-02, DISC-23 (uncertainty propagation)</related-comment>
    </step>

    <step id="2.5">
      <task>Add citations for discussion claims</task>
      <related-comments>DISC-06, DISC-08, DISC-16, DISC-25, DISC-27, DISC-28</related-comments>
      <action>Review manuscript-comments.xml THEME-1 for all missing citations</action>
    </step>
  </phase>

  <!-- PHASE 3: INTRODUCTION.TEX UPDATES -->
  <phase id="3-introduction" name="Introduction Section Updates">
    <file>introduction.tex</file>

    <step id="3.1">
      <task>Add ophthalmic FM context (OBLIGATORY)</task>
      <location>Before TSFM introduction</location>
      <related-comment>INTRO-09 (RetFound, oculomics)</related-comment>
      <text><![CDATA[
Foundation models for ophthalmic imaging have demonstrated remarkable
generalizability, with RetFound~\citep{zhou_foundation_2023} achieving
state-of-the-art performance across multiple retinal pathologies and
even systemic disease detection---exemplifying the emerging paradigm of
``oculomics''~\citep{wagner_systemic_2020}. While image-based foundation
models have flourished, time-series foundation models for ophthalmic
signals remain largely unexplored.
      ]]></text>
    </step>

    <step id="3.2">
      <task>Add MIRA citation (OBLIGATORY)</task>
      <location>After MOMENT/UniTS/TimesNet mention</location>
      <related-comment>INTRO-10 (MIRA, generalist vs specialist)</related-comment>
      <text><![CDATA[
Recently, MIRA~\citep{li_mira_2025} demonstrated that medical-specific TSFM
pretraining on ICU physiological signals can outperform generalist models,
raising questions about the generalist-vs-specialist tradeoff first
characterized by~\citet{kataria_generalist_2025}.
      ]]></text>
    </step>

    <step id="3.3">
      <task>Add explicit novelty statement</task>
      <location>End of introduction, before structure paragraph</location>
      <related-comment>INTRO-12 (novelty statement missing)</related-comment>
      <text><![CDATA[
To our knowledge, this is the first systematic evaluation of time-series
foundation models for pupillometry preprocessing. Our contributions are:
(1) demonstrating that generic TSFMs achieve competitive preprocessing
quality without domain-specific training; (2) quantifying how preprocessing
choices propagate to downstream classification across 407 configurations;
(3) providing STRATOS-compliant benchmarks for future PLR foundation model
development.
      ]]></text>
    </step>
  </phase>

  <!-- PHASE 4: CROSS-REFERENCE VERIFICATION -->
  <phase id="4-verification" name="Cross-Reference Verification">

    <step id="4.1">
      <task>Verify all numbers match between results.tex and discussion.tex</task>
      <critical>No conflicting AUROC values allowed</critical>
    </step>

    <step id="4.2">
      <task>Verify figure references match captions</task>
      <critical>No orphan figure references</critical>
    </step>

    <step id="4.3">
      <task>Run LaTeX compilation</task>
      <command>cd /home/petteri/Dropbox/github-personal/sci-llm-writer/manuscripts && make TEX=foundationPLR/foundation-plr-manuscript.tex</command>
    </step>
  </phase>

  <!-- SUCCESS CRITERIA -->
  <success-criteria>
    <criterion>EPV = 7.0 stated correctly in methods</criterion>
    <criterion>Pilot study framing explicit in discussion</criterion>
    <criterion>No placeholder numbers remain (-?-, 0.???)</criterion>
    <criterion>RetFound/oculomics context added (OBLIGATORY)</criterion>
    <criterion>MIRA citation added (OBLIGATORY)</criterion>
    <criterion>Novelty statement present in introduction</criterion>
    <criterion>All numbers consistent between sections</criterion>
    <criterion>LaTeX compiles without errors</criterion>
  </success-criteria>

  <!-- RELATED DOCUMENTS -->
  <related-documents>
    <document path="manuscript-comments.xml">41 author comments with tracking status</document>
    <document path="CLAUDE.md">Manuscript scope and critical numbers</document>
    <document path="figure-reports-expert-review-v2.md">Verified metrics and findings</document>
  </related-documents>
</execution-plan>
